345 related articles for article (PubMed ID: 30187864)
1. The safety and efficacy of four different fixed combination regimens of adapalene 0.1%/benzoyl peroxide 2.5% gel for the treatment of acne vulgaris: results from a randomised controlled study.
Tan J; Bissonnette R; Gratton D; Kerrouche N; Canosa JM
Eur J Dermatol; 2018 Aug; 28(4):502-508. PubMed ID: 30187864
[TBL] [Abstract][Full Text] [Related]
2. The tolerability profile of clindamycin 1%/benzoyl peroxide 5% gel vs. adapalene 0.1%/benzoyl peroxide 2.5% gel for facial acne: results of a randomized, single-blind, split-face study.
Gonzalez P; Vila R; Cirigliano M
J Cosmet Dermatol; 2012 Dec; 11(4):251-60. PubMed ID: 23174047
[TBL] [Abstract][Full Text] [Related]
3. Moderate and Severe Inflammatory Acne Vulgaris Effectively Treated with Single-Agent Therapy by a New Fixed-Dose Combination Adapalene 0.3 %/Benzoyl Peroxide 2.5 % Gel: A Randomized, Double-Blind, Parallel-Group, Controlled Study.
Stein Gold L; Weiss J; Rueda MJ; Liu H; Tanghetti E
Am J Clin Dermatol; 2016 Jun; 17(3):293-303. PubMed ID: 26945741
[TBL] [Abstract][Full Text] [Related]
4. Preadolescent moderate acne vulgaris: a randomized trial of the efficacy and safety of topical adapalene-benzoyl peroxides.
Eichenfield LF; Draelos Z; Lucky AW; Hebert AA; Sugarman J; Stein Gold L; Rudisill D; Liu H; Manna V
J Drugs Dermatol; 2013 Jun; 12(6):611-8. PubMed ID: 23839175
[TBL] [Abstract][Full Text] [Related]
5. Adapalene/Benzoyl Peroxide Gel 0.3%/2.5%: Effective Acne Therapy Regardless of Age or Gender.
Stein Gold L; Werschler WP; Mohawk J
J Drugs Dermatol; 2017 Jun; 16(6):582-589. PubMed ID: 28686776
[TBL] [Abstract][Full Text] [Related]
6. Adapalene/Benzoyl Peroxide Gel 0.3%/2.5%: A Safe and Effective Acne Therapy in All Skin Phototypes.
Alexis AF; Cook-Bolden FE; York JP
J Drugs Dermatol; 2017 Jun; 16(6):574-581. PubMed ID: 28686775
[TBL] [Abstract][Full Text] [Related]
7. A North American study of adapalene-benzoyl peroxide combination gel in the treatment of acne.
Gold LS; Tan J; Cruz-Santana A; Papp K; Poulin Y; Schlessinger J; Gidner J; Liu Y; Graeber M;
Cutis; 2009 Aug; 84(2):110-6. PubMed ID: 19746769
[TBL] [Abstract][Full Text] [Related]
8. Combination therapy with adapalene-benzoyl peroxide and oral lymecycline in the treatment of moderate to severe acne vulgaris: a multicentre, randomized, double-blind controlled study.
Dréno B; Kaufmann R; Talarico S; Torres Lozada V; Rodríguez-Castellanos MA; Gómez-Flores M; De Maubeuge J; Berg M; Foley P; Sysa-Jedrzejowska A; Kerrouche N; Paliargues F; Bettoli V
Br J Dermatol; 2011 Aug; 165(2):383-90. PubMed ID: 21495995
[TBL] [Abstract][Full Text] [Related]
9. Tolerability and Efficacy of Clindamycin/Tretinoin versus Adapalene/Benzoyl Peroxide in the Treatment of Acne Vulgaris.
Aschoff R; Möller S; Haase R; Kuske M
J Drugs Dermatol; 2021 Mar; 20(3):295-301. PubMed ID: 33683070
[TBL] [Abstract][Full Text] [Related]
10. The efficacy, safety, and tolerability of adapalene versus benzoyl peroxide in the treatment of mild acne vulgaris: a randomized trial.
Babaeinejad SH; Fouladi RF
J Drugs Dermatol; 2013 Jul; 12(7):790-4. PubMed ID: 23884492
[TBL] [Abstract][Full Text] [Related]
11. Do tutorials on application method enhance adapalene-benzoyl peroxide combination gel tolerability in the treatment of acne?
Kwon HH; Park SY; Yoon JY; Min S; Suh DH
J Dermatol; 2015 Nov; 42(11):1058-65. PubMed ID: 26096777
[TBL] [Abstract][Full Text] [Related]
12. Combination of benzoyl peroxide 5% gel with liquid cleanser and moisturizer SPF 30 in acne treatment results in high levels of subject satisfaction, good adherence and favorable tolerability.
Kim MR; Kerrouche N
J Dermatolog Treat; 2018 Feb; 29(1):49-54. PubMed ID: 28678647
[TBL] [Abstract][Full Text] [Related]
13. Adapalene-benzoyl peroxide once-daily, fixed-dose combination gel for the treatment of acne vulgaris: a randomized, bilateral (split-face), dose-assessment study of cutaneous tolerability in healthy participants.
Andres P; Pernin C; Poncet M
Cutis; 2008 Mar; 81(3):278-84. PubMed ID: 18441854
[TBL] [Abstract][Full Text] [Related]
14. A 6-month maintenance therapy with adapalene-benzoyl peroxide gel prevents relapse and continuously improves efficacy among patients with severe acne vulgaris: results of a randomized controlled trial.
Poulin Y; Sanchez NP; Bucko A; Fowler J; Jarratt M; Kempers S; Kerrouche N; Dhuin JC; Kunynetz R
Br J Dermatol; 2011 Jun; 164(6):1376-82. PubMed ID: 21457209
[TBL] [Abstract][Full Text] [Related]
15. Patient-Reported Outcomes in Acne Patients With Skin of Color Using Adapalene 0.3%-Benzoyl Peroxide 2.5%: A Prospective Real-World Study.
DuBois J; Ong GCW; Petkar G; Almeida LMC; Chavda R; Kerrouche N; Alexis AF
J Drugs Dermatol; 2019 Jun; 18(5):514. PubMed ID: 31251543
[TBL] [Abstract][Full Text] [Related]
16. Accelerated Onset of Action and Increased Tolerability in Treating Acne With a Fixed-Dose Combination Gel.
Friedman A; Waite K; Brandt S; Meckfessel MH
J Drugs Dermatol; 2016 Feb; 15(2):231-6. PubMed ID: 26885793
[TBL] [Abstract][Full Text] [Related]
17. Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients.
Gollnick HP; Draelos Z; Glenn MJ; Rosoph LA; Kaszuba A; Cornelison R; Gore B; Liu Y; Graeber M;
Br J Dermatol; 2009 Nov; 161(5):1180-9. PubMed ID: 19466959
[TBL] [Abstract][Full Text] [Related]
18. Clindamycin phosphate 1.2%/benzoyl peroxide 3% fixed-dose combination gel versus topical combination therapy of adapalene 0.1% gel and clindamycin phosphate 1.2% gel in the treatment of acne vulgaris in Japanese patients: A multicenter, randomized, investigator-blind, parallel-group study.
Hayashi N; Kurokawa I; Siakpere O; Endo A; Hatanaka T; Yamada M; Kawashima M
J Dermatol; 2018 Aug; 45(8):951-962. PubMed ID: 29905384
[TBL] [Abstract][Full Text] [Related]
19. Clindamycin phosphate 1·2%-benzoyl peroxide 3·0% fixed-dose combination gel has an effective and acceptable safety and tolerability profile for the treatment of acne vulgaris in Japanese patients: a phase III, multicentre, randomised, single-blinded, active-controlled, parallel-group study.
Kawashima M; Hashimoto H; Alió Sáenz AB; Ono M; Yamada M
Br J Dermatol; 2015 Feb; 172(2):494-503. PubMed ID: 25040180
[TBL] [Abstract][Full Text] [Related]
20. Customized Single-agent Therapy Management of Severe Inflammatory Acne: A Randomized, Double-blind, Parallel-group, Controlled Study of a New Treatment--Adapalene 0.3%-Benzoyl Peroxide 2.5% Gel.
Weiss J; Stein Gold L; Leoni M; Rueda MJ; Liu H; Tanghetti E
J Drugs Dermatol; 2015 Dec; 14(12):1427-35. PubMed ID: 26659936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
